Resistin in morbidly obese patients before and after gastric bypass surgery | Zendy

Elena Parreño Caparrós | Zendy; Fátima Illán Gómez | Zendy; Manuel Gonzálvez Ortega | Zendy; Isabel Orea Soler | Zendy; Matías Pérez Paredes | Zendy; Marı́a Luisa Lozano | Zendy; Elena Arjonilla Sampedro | Zendy; M a Soledad Alcaraz Tafalla | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Resistin in morbidly obese patients before and after gastric bypass surgery

Author(s) -

Elena Parreño Caparrós,

Fátima Illán Gómez,

Manuel Gonzálvez Ortega,

Isabel Orea Soler,

Matías Pérez Paredes,

Marı́a Luisa Lozano,

Elena Arjonilla Sampedro,

M a Soledad Alcaraz Tafalla

Publication year - 2017

Publication title -

nutrición hospitalaria

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.31

H-Index - 53

eISSN - 1699-5198

pISSN - 0212-1611

DOI - 10.20960/nh.1028

Subject(s) - resistin , medicine , insulin resistance , adiponectin , glycated hemoglobin , body mass index , weight loss , endocrinology , dyslipidemia , obesity , diabetes mellitus , type 2 diabetes

Resistin was originally suggested to be a potential mediator of obesity-related insulin resistance in rodents. However, in humans, the role of resistin in obesity and insulin resistance has not yet been demonstrated. The present study investigates whether there are differences in resistin levels between patients with morbid obesity and lean subjects, and analyzes changes in resistin levels after significant weight loss secondary to bariatric surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research